Severe COVID-19 Disables Disease-Fighting Immune Circuit
Patients with severe COVID-19 produce antibodies that paradoxically shut down their immune system’s virus-fighting response just when they need it most.
Displaying 181 - 210 of 334
-
-
How Can We Be Sure the New COVID-19 Vaccines Are Safe?
We asked several UCSF experts for a personal take on what will convince them that a vaccine is safe.
-
New COVID-19 Testing Approach Measures Patients’ Immune Response for Better Diagnosis
This type of test could be used as a check against possible errors generated by the standard tests that directly detect the SARS-CoV-2 virus, the scientists said.
-
Novel Tool Deciphers Cells’ Energetic Code to Enhance Anticancer Therapies
Immunotherapies are a promising anticancer arsenal and work by mobilizing the immune system to recognize and destroy cancer cells. Currently, however, only a third of patients respond to
-
Big Data Powers Design of ‘Smart’ Cell Therapies for Cancer
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research.
-
Gut Immune Cells May Help Send Multiple Sclerosis Into Remission
An international research team led by UCSF scientists has shown, for the first time, that gut immune cells travel to the brain during multiple sclerosis flare-ups in patients.
-
11 UCSF Research Specialties Rank in Top 10 in US News Global Universities Rankings for 2021
Now in their seventh year, the Best Global Universities rankings focus on schools’ academic research and reputation overall instead of specific undergraduate and graduate programs. These global rankings help the increasing number of students exploring international higher education options to more accurately compare institutions around the world.
-
Archive: Cancer Immunotherapy ‘Uniquely Suppressed’ by Liver Tumors
Though cancer immunotherapy has become a promising standard-of-care treatment – and in some cases, perhaps a cure – for a wide variety of different cancers, it doesn’t work for everyone, and researchers have increasingly turned their attention to understanding why.
-
Archive: UCSF Researchers Test New COVID-19 Drug
-
Do Masks Provide a Just-Right Dose of Coronavirus?
Infectious diseases expert Monica Gandhi, MD, MPH, explores her hypothesis that one of the benefits of masks may be that they provide exposure to enough coronavirus to build immunity but not enough to cause illness.
-
Archive: To Treat Frontotemporal Dementia, Treat the Brain’s Immune Cells
Though FTD is not as well known as Alzheimer’s disease, it’s the second most common cause of dementia in people under 65, and there’s currently no treatment.
-
Archive: Immune Cells in Spinal Fluid of Multiple Sclerosis Patients Identified as Likely Disease Drivers
New UCSF research sheds light on how immune system B cells that infiltrate the central nervous system may drive multiple sclerosis.
-
Archive: In Tiny Llama Antibodies, Researchers See Hope for a Coronavirus Treatment
-
Archive: How COVID Sends Some Bodies to War With Themselves
-
We Must Learn from Our Past
A look at past outbreaks offers guidance on bringing the current one to an end – and on thwarting the next one.
-
We Thought It Was Just a Respiratory Virus
UCSF researchers are taking a closer look at COVID-19’s dizzying array of symptoms to get at the disease’s root causes.
-
How to Build a COVID Testing Lab in Eight Days
As the United States’ testing regime floundered early in the pandemic, scientists at UCSF and the Chan Zuckerberg Biohub created from scratch a diagnostic lab that became a model for the nation.
-
COVID-19 Frontliners: Searching for the Silver Bullet
Clinical trial leader Annie Luetkemeyer, MD, tests promising therapies for COVID-19 – and soon a vaccine.
-
Tweeting a Pandemic
How I learned to use social media to advance the public’s understanding of COVID-19.
-
Seeking Immunity Against COVID-19
Joel Ernst, MD, addresses key questions about how vaccine development works and why vaccines are especially important in the case of COVID-19.
-
Archive: Living With COVID-19 When It Won't Go Away
-
Archive: UCSF, St. Jude Identify Key Culprit Driving Treatment Resistance in Deadly Immune Disorder
The finding could offer additional insights into other immune conditions, including a type of childhood leukemia and the severe inflammation response in some children with COVID-19.
-
Archive: Rare, Super Coronavirus Antibodies Likely to Yield Vaccine, Say Stanford, UCSF Experts
-
Archive: Tumors Disrupt the Immune System Throughout the Body
Depending on a cancer’s tissue of origin, tumors cause widespread and variable disruption of the immune system throughout the body, not just at the primary tumor site.
-
Archive: UCSF Cancer Researchers Present New Advances at ASCO 2020
Cancer specialists from UCSF will present new research findings at the annual scientific program of the American Society of Clinical Oncology, the world’s largest clinical cancer research meeting.
-
Archive: The Disappointing Truth About Antibody Testing
-
Archive: Flipping A Genetic Switch on Cells Lets Researchers Boost or Suppress Immune Responses
Cancer and autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, might not seem to have much in common, but some researchers now are pinning hopes on the same immune system cell –
-
Archive: Testing the Tests: COVID-19 Antibody Assays Scrutinized for Accuracy by UCSF, UC Berkeley Researchers
A project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.
-
Archive: Coronavirus Antibody Tests: Can You Trust the Results?
-
Archive: Two Drugs Studied in Bay Area Could Lessen Coronavirus Deaths, Hospitalizations